The lesion produced by alcohol ablation depends on more than ethanol concentration alone. Dose influences the extent of tissue injury, while the delivery route determines how ethanol reaches the target. Tissue anatomy also shapes spread and confinement, so clinicians must account for these variables when aiming for a therapeutic lesion that limits damage nearby.
Concentrated ethanol acts through several linked tissue effects. It disrupts cell membranes and proteins, causes local dehydration, and produces coagulative necrosis, meaning destruction of tissue with protein coagulation. These changes destroy or disable the targeted region rather than relying on a temporary functional effect, which helps explain its use against abnormal growth, obstruction, or electrical activity.
After ethanol reaches the target, vascular thrombosis may reduce local blood flow and contribute to the final lesion. Subsequent scar formation can consolidate the treated area and alter its structure or function. This sequence matters clinically because the desired result depends on creating a sufficiently localized injury, not simply introducing ethanol into tissue.
A typical treatment workflow places a needle or catheter at the selected target, delivers concentrated ethanol, and uses imaging and clinical monitoring to assess positioning and limit injury to nearby structures. The route is chosen according to the anatomy and condition being treated, while the delivered dose helps determine the resulting lesion.
Clinicians may consider alcohol ablation for hypertrophic obstructive cardiomyopathy, certain tumors, cysts, and pain-producing nerve pathways. The therapeutic goal differs by condition: reducing obstruction, destroying abnormal growth or cyst tissue, or disrupting a pathway associated with pain. These applications illustrate why target selection and anatomy must be matched to the clinical problem.
The procedure can reduce abnormal growth, obstruction, or electrical activity, depending on the target, and it may also address pain generated by selected nerve pathways. Its outcome is not uniform across conditions: lesion size and effect vary with dose, delivery route, and anatomy. Imaging and monitoring support evaluation of benefit while limiting injury to surrounding structures.